ProShares Ultra Nasdaq Biotechnology 2X Shares

BIBNASDAQ · USD
117.48USD+4.82 (+4.27%)

ProShares Ultra Nasdaq Biotechnology 2X Shares (BIB) Implied Volatility Current

BIB's 30 day implied volatility is 57.47%, with an IV Rank of 96.43%. This is a high IV Rank versus the past year, meaning ProShares Ultra Nasdaq Biotechnology 2X Shares options are relatively expensive and currently favor sellers. BIB's 30 day historical volatility sits at 58.19%, which means implied volatility is running roughly in line with historical volatility, as of Nov 5, 2026.

Read more

Tracking BIB implied volatility helps you spot when ProShares Ultra Nasdaq Biotechnology 2X Shares options are historically cheap or expensive, and where the best trades are hiding. When BIB IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor BIB implied volatility current levels in real time and filter for high probability trades.

Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking BIB IV rank helps you see whether BIB's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.

Implied Volatility

IV Rank
96.43%IV Rank
High

IV is highly elevated. Premiums are expensive, strongly favoring sellers.

Implied Volatility (30d)57.47%

IV Rank96.43%

Historical Volatility (30d)58.19%

IV Minus HV-0.72%

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →